Literature DB >> 1692701

Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulphate.

J F Bateman1, S B Golub.   

Abstract

The culture of skin fibroblasts in the presence of 0.01% (w/v) dextran sulphate results in complete proteolytic processing of procollagen to collagen. Processing occurs predominantly via a pN-collagen intermediate, suggesting that C-propeptide cleavage occurs early during the processing pathway. The processed collagen is associated with the cell-layer fraction. This method of inducing procollagen processing was evaluated for use in detecting procollagen processing abnormalities in heritable connective-tissue diseases. Abnormal type I procollagen processing was clearly demonstrated in two cases with known defects of pN-propeptide cleavage. In one, the cleavage deficiency was due to diminished N-proteinase activity (dermatosparaxis) and in the other case (Ehler's-Danlos syndrome type VIIA) the cleavage site was deleted. In a case of osteogenesis imperfecta (type II) the slow electrophoretic migration of type I collagen alpha-chains due to over-modification of lysine was readily demonstrated. Inefficient procollagen processing was also evident in this patient, as had been previously reported [de Wet, Pihlanjaniemi, Myers, Kelly & Prockop (1983) J. Biol. Chem. 258, 7721-7728]. Thus this method of culture in the presence of dextran sulphate provides a simple and rapid procedure for the detection of procollagen processing defects and electrophoretic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692701      PMCID: PMC1131335          DOI: 10.1042/bj2670573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

Review 2.  Cross-linking in collagen and elastin.

Authors:  D R Eyre; M A Paz; P M Gallop
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

3.  A possible mechanism for the regulation of collagen fibril diameter in vivo.

Authors:  D J Hulmes
Journal:  Coll Relat Res       Date:  1983-07

4.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

5.  Collagen fibril formation during embryogenesis.

Authors:  R Fleischmajer; B R Olsen; R Timpl; J S Perlish; O Lovelace
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Cathepsin D-mediated processing of procollagen: lysosomal enzyme involvement in secretory processing of procollagen.

Authors:  D L Helseth; A Veis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Processing of procollagen types III and I in cultured bovine smooth muscle cells.

Authors:  L Gerstenfeld; J C Beldekas; G E Sonenshein; C Franzblau
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

8.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

Authors:  J Bonadio; P H Byers
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

9.  Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases.

Authors:  M Miyahara; F K Njieha; D J Prockop
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

10.  Precipitation of collagens by polyethylene glycols.

Authors:  J A Ramshaw; J F Bateman; W G Cole
Journal:  Anal Biochem       Date:  1984-09       Impact factor: 3.365

View more
  11 in total

1.  Effect of dextran on synthesis, secretion and deposition of type III procollagen in cultured human fibroblasts.

Authors:  A Jukkola; J Risteli; L Risteli
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

2.  Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.

Authors:  L T Smith; W Wertelecki; L M Milstone; E M Petty; M R Seashore; I M Braverman; T G Jenkins; P H Byers
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.

Authors:  A C Nicholls; J E Oliver; S McCarron; J B Harrison; D S Greenspan; F M Pope
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

4.  Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis.

Authors:  Thomas Später; Marisa Assunção; Kwok Keung Lit; Guidong Gong; Xiaoling Wang; Yi-Yun Chen; Ying Rao; Yucong Li; Chi Him Kendrick Yiu; Matthias W Laschke; Michael D Menger; Dan Wang; Rocky S Tuan; Kay-Hooi Khoo; Michael Raghunath; Junling Guo; Anna Blocki
Journal:  Bioact Mater       Date:  2022-04-02

5.  A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.

Authors:  N S Vasan; H Kuivaniemi; B E Vogel; R R Minor; J A Wootton; G Tromp; R Weksberg; D J Prockop
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

6.  EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta.

Authors:  Fleur S van Dijk; Peter H Byers; Raymond Dalgleish; Fransiska Malfait; Alessandra Maugeri; Marianne Rohrbach; Sofie Symoens; Erik A Sistermans; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

7.  Macromolecular crowding meets oxygen tension in human mesenchymal stem cell culture - A step closer to physiologically relevant in vitro organogenesis.

Authors:  Daniela Cigognini; Diana Gaspar; Pramod Kumar; Abhigyan Satyam; Senthilkumar Alagesan; Clara Sanz-Nogués; Matthew Griffin; Timothy O'Brien; Abhay Pandit; Dimitrios I Zeugolis
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

8.  A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta.

Authors:  M Mottes; A Sangalli; M Valli; A Forlino; M Gomez-Lira; F Antoniazzi; C D Constantinou-Deltas; G Cetta; P F Pignatti
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

9.  Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain.

Authors:  L Bruckner-Tuderman; O Nilssen; D R Zimmermann; M T Dours-Zimmermann; D U Kalinke; T Gedde-Dahl; J O Winberg
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

10.  Effects of collagen-derived bioactive peptides and natural antioxidant compounds on proliferation and matrix protein synthesis by cultured normal human dermal fibroblasts.

Authors:  Suzanne Edgar; Blake Hopley; Licia Genovese; Sara Sibilla; David Laight; Janis Shute
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.